Principal Financial Group
TEVA icon

Principal Financial Group’s Teva Pharmaceuticals TEVA Stock Holding History

Principal Financial Group’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.04M Sell
89,643
-7,626
-8% -$254K ﹤0.01% 1781
2026
Q1 		$2.93M Sell
97,269
-30,649
-24% -$986K ﹤0.01% 1771
2025
Q4 		$3.99M Buy
127,918
+53,525
+72% +$1.32M ﹤0.01% 1686
2025
Q3 		$1.5M Buy
74,393
+1,346
+2% +$23.6K ﹤0.01% 1859
2025
Q2 		$1.22M Sell
73,047
-7,388
-9% -$119K ﹤0.01% 1858
2025
Q1 		$1.24M Sell
80,435
-12,036
-13% -$215K ﹤0.01% 1829
2024
Q4 		$2.04M Buy
92,471
+2,752
+3% +$50.1K ﹤0.01% 1796
2024
Q3 		$1.62M Sell
89,719
-17,697
-16% -$310K ﹤0.01% 1800
2024
Q2 		$1.75M Sell
107,416
-8,031
-7% -$124K ﹤0.01% 1790
2024
Q1 		$1.63M Sell
115,447
-3,890
-3% -$49K ﹤0.01% 1807
2023
Q4 		$1.25M Sell
119,337
-8,260
-6% -$77.1K ﹤0.01% 1811
2023
Q3 		$1.3M Sell
127,597
-12,305
-9% -$115K ﹤0.01% 1809
2023
Q2 		$1.05M Buy
139,902
+29,296
+26% +$238K ﹤0.01% 1837
2023
Q1 		$979K Sell
110,606
-2,375
-2% -$23.5K ﹤0.01% 1855
2022
Q4 		$1.03M Buy
112,981
+4,491
+4% +$39.2K ﹤0.01% 1858
2022
Q3 		$875K Sell
108,490
-26,203
-19% -$232K ﹤0.01% 1862
2022
Q2 		$1.01M Sell
134,693
-5,134
-4% -$44.7K ﹤0.01% 1917
2022
Q1 		$1.31M Buy
139,827
+3,147
+2% +$26.3K ﹤0.01% 1928
2021
Q4 		$1.09M Sell
136,680
-17,199
-11% -$155K ﹤0.01% 1966
2021
Q3 		$1.5M Buy
153,879
+2,233
+1% +$20.9K ﹤0.01% 1918
2021
Q2 		$1.5M Buy
151,646
+22,874
+18% +$242K ﹤0.01% 1966
2021
Q1 		$1.49M Buy
128,772
+9,631
+8% +$110K ﹤0.01% 1912
2020
Q4 		$1.15M Sell
119,141
-12,822
-10% -$123K ﹤0.01% 1915
2020
Q3 		$1.19M Sell
131,963
-17,382
-12% -$184K ﹤0.01% 1833
2020
Q2 		$1.84M Sell
149,345
-719
-0.5% -$8.13K ﹤0.01% 1713
2020
Q1 		$1.35M Buy
150,064
+25,753
+21% +$264K ﹤0.01% 1688
2019
Q4 		$1.22M Buy
124,311
+37,289
+43% +$333K ﹤0.01% 1804
2019
Q3 		$599K Sell
87,022
-45,167
-34% -$346K ﹤0.01% 1912
2019
Q2 		$1.22M Sell
132,189
-2,850,899
-96% -$34.4M ﹤0.01% 1813
2019
Q1 		$46.8M Buy
2,983,088
+380,496
+15% +$6.71M 0.04% 406
2018
Q4 		$40.1M Buy
2,602,592
+1,691,013
+186% +$34.7M 0.04% 412
2018
Q3 		$19.6M Buy
911,579
+797,295
+698% +$18.5M 0.02% 870
2018
Q2 		$2.78M Buy
114,284
+3,390
+3% +$69.1K ﹤0.01% 1713
2018
Q1 		$1.9M Sell
110,894
-957
-0.9% -$18.7K ﹤0.01% 1742
2017
Q4 		$2.12M Sell
111,851
-7,659
-6% -$115K ﹤0.01% 1749
2017
Q3 		$2.1M Sell
119,510
-4,664
-4% -$105K ﹤0.01% 1727
2017
Q2 		$4.13M Buy
124,174
+21,658
+21% +$670K ﹤0.01% 1610
2017
Q1 		$3.29M Sell
102,516
-6,484
-6% -$221K ﹤0.01% 1648
2016
Q4 		$3.95M Buy
+109,000
New +$4.35M 0.01% 1591
2016
Q3 		– Sell
-687,449
Closed -$34.5M – 2196
2016
Q2 		$34.5M Sell
687,449
-1,116,051
-62% -$59.4M 0.05% 369
2016
Q1 		$96.5M Buy
1,803,500
+4,258
+0.2% +$250K 0.14% 166
2015
Q4 		$118M Buy
1,799,242
+166,879
+10% +$10.3M 0.18% 147
2015
Q3 		$92.2M Buy
1,632,363
+931,632
+133% +$60.4M 0.14% 180
2015
Q2 		$41.4M Buy
700,731
+3,553
+0.5% +$219K 0.06% 308
2015
Q1 		$43.4M Buy
697,178
+488,996
+235% +$28.4M 0.06% 304
2014
Q4 		$12M Buy
208,182
+26,455
+15% +$1.47M 0.02% 826
2014
Q3 		$9.77M Buy
+181,727
New +$9.63M 0.02% 915

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Principal Financial Group's TEVA Position: Q2 2026 in Review

Principal Financial Group reduced its Teva Pharmaceuticals (TEVA) stake by 7.8% in Q2 2026, selling an estimated $254K and leaving 89,643 shares worth $3.04M. The position accounts for ﹤0.01% of the portfolio, ranked #1781.

Principal Financial Group first reported a position in TEVA in Q3 2014 and has held it in 47 quarters since. The position peaked at $118M in Q4 2015. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Principal Financial Group held 89,643 shares of Teva Pharmaceuticals worth $3.04M as of Q2 2026.
  • Principal Financial Group sold 7,626 Teva Pharmaceuticals shares in Q2 2026, an estimated $254K.
  • Teva Pharmaceuticals made up ﹤0.01% of Principal Financial Group's portfolio in Q2 2026, its #1781 holding.
  • Principal Financial Group first reported a position in Teva Pharmaceuticals in Q3 2014 and has held it in 47 quarters since.
  • Principal Financial Group's Teva Pharmaceuticals position peaked at $118M in Q4 2015.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.